Oliver Wyman Completes Acquisition of Huron’s Life Sciences Strategy Consulting Practice
November 02 2021 - 9:04AM
Business Wire
Oliver Wyman, a global management consulting firm and a business
of Marsh McLennan (NYSE: MMC), today completed the acquisition of
Huron’s life sciences strategy consulting practice. Terms of the
acquisition were not disclosed.
“Through this combination, we will continue our relentless
pursuit of a better way in healthcare, partnering with
pharmaceutical, biotechnology, and medical device companies. Our
new colleagues bring the expertise needed to help life sciences
companies tackle their most pressing strategic questions, including
increasingly complex commercialization and access-related issues,”
commented Sam Glick, Partner and Global Leader of Health and Life
Sciences at Oliver Wyman.
“Combining the deep industry expertise of the Huron Life
Sciences team with Oliver Wyman’s global scale and capabilities,
will help us holistically address the challenges of the life
sciences sector,” said John Westwood, Partner and Global Life
Sciences Business Leader at Oliver Wyman and former Global Life
Sciences Practice Leader at Huron. “Now as part of Oliver Wyman, we
look forward to working side-by-side with our clients to help shape
healthcare’s future.”
The acquisition advances Oliver Wyman’s leadership in life
sciences strategy consulting, helping the firm deliver critical
commercial strategy, marketing, pricing, market access, and R&D
advice to a broader set of clients.
The acquisition also grows Oliver Wyman’s deep bench of talent,
adding 80 professionals, including 12 partners, to its Health and
Life Sciences practice. These senior professionals have
longstanding relationships with many of the world’s top
pharmaceutical, biotechnology, diagnostics, and medical device
companies.
About Oliver Wyman Oliver Wyman is a global leader in
management consulting. With offices in 60 cities across 29
countries, Oliver Wyman combines deep industry knowledge with
specialized expertise in strategy, operations, risk management, and
organization transformation. The firm has more than 5,000
professionals around the world who work with clients to optimize
their business, improve their operations and risk profile, and
accelerate their organizational performance to seize the most
attractive opportunities. Oliver Wyman is a business of Marsh
McLennan (NYSE: MMC). For more information, visit
www.oliverwyman.com. Follow Oliver Wyman on Twitter
@OliverWyman.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211102005721/en/
Francine Minadeo Oliver
Wyman +1
917-573-8826 Francine.minadeo@oliverwyman.com
Marsh and McLennan Compa... (NYSE:MMC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Marsh and McLennan Compa... (NYSE:MMC)
Historical Stock Chart
From Sep 2023 to Sep 2024